期刊文献+

替比培南侧链的合成工艺研究 被引量:1

Study on Synthetic Technology of Tebipenem Side Chain
下载PDF
导出
摘要 替比培南侧链是合成目前世界上唯一的口服型碳青霉烯类抗生素替比培南酯的关键中间体。以苄胺和和环氧氯丙烷为起始原料,经开环、分子内环合、甲磺酰化、催化氢化、缩合、S_N2取代、碱性水解和酸化等8步反应合成了替比培南侧链,工艺总收率52.6%,其结构得到~1H-NMR和IR确认。该方法原料廉价易得、反应条件温和、操作简单、收率高、成本低,适合工业化生产。 Tebipenem pivoxil is the only oral carbapenem antibiotic in the world. The key intermidiate of tebipenem pivoxil,tebipenem side chain,was synthesized from benzylamine and epichlorohydrin by ring opening,cyclization,mesylation,catalytic hydrogenation,condensation,S_N2 substitution,hydrolysis and acidification. The overall yield was56%. The structure was confirmed by ~1H-NMR and IR. The method has merits of cheap raw materials,mild conditions,simple operation,high yield,low cost and suitability for industrialization.
出处 《广州化工》 CAS 2018年第1期60-61,共2页 GuangZhou Chemical Industry
关键词 替比培南酯 碳青霉烯类 关键中间体 合成 tebipenem pivoxil carbapenems key intermediate synthesis
  • 相关文献

参考文献5

二级参考文献67

  • 1刘萍,边强.碳青霉烯类抗生素ertapenem[J].世界临床药物,2004,25(7):441-441. 被引量:3
  • 2范亚平.细菌对碳青霉烯类抗生素耐药的机制及对策[J].中国医学文摘(内科学),2005,26(1):123-125. 被引量:3
  • 3黄金竹,母连军.碳青霉烯类抗生素的研究概况[J].国外医药(抗生素分册),2007,28(4):145-154. 被引量:45
  • 4Abe T,Hayashi K,Mihira A,et al.L-084,a new oral carbapenem:Synthesis and structure-activity relationships of C2substituted 1beta-methylcarbapenems.38th Intersci Conf Antimicrob Agents Chemother (ICAAC),(Sept 24-27,San Diego),1998,Abst F-64.
  • 5Isoda T,Sato C,Mihira A,et al.(Wyeth-Lederle Japan,Ltd.).2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thiocarbapenem derivatives.EP 0632039,EP 0717042,JP 1996053453,US 5534510,US 5659043,US 5783703.
  • 6Kumagai T.(Wyeth-Lederle Japan,Ltd.).Carbapenem-3-carboxylic acid ester derivatives.EP 0808315,JP 1999504039,US 5886172,WO 9721712.
  • 7Yasuda S,Okue M,Hori N.(Meiji Seika Kaisha,Ltd).Process for producing carbapenem derivative and intermediate for use in the production.WO 2004035539.
  • 8Nishino K,Koga T.(Kaneka Corporation).Process for producing carbapenem compound for oral administration.EP 1580191.
  • 9西野敬太,古贺照义.经口给药用碳青霉素烯化合物的新的合成中间体及其制造方法.CN1708504A.
  • 10Kato N,Kato H,Tanaka K,Watanabe K.L-084,a new oral carbapenem:In vitro activity against anaerobic bacteria.38th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 24-27,San Diego),1998,Abst F-70.

共引文献64

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部